Temat: "Standard of Care" - OpacWWW

Skocz do pozycji: 1 1.

Tytuł :: Perineal trauma management and follow-up: Are we meeting the standard of care?
Autorzy :: Peiris-John R; Section of Epidemiology and Biostatistics, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
Park CYM; Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
Wells S; Section of Epidemiology and Biostatistics, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
Kool B; Section of Epidemiology and Biostatistics, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
Wise MR; Department of Obstetrics and Gynaecology, School of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.; Pokaż więcej
Źródło :: The Australian & New Zealand journal of obstetrics & gynaecology [Aust N Z J Obstet Gynaecol] 2021 Feb; Vol. 61 (1), pp. 22-29. Date of Electronic Publication: 2020 Oct 22.
Typ publikacji :: Journal Article; Review
MeSH Terms :: Perineum*/surgery
Standard of Care*
Clinical Audit ; Episiotomy ; Humans ; New Zealand ; Parturition
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 2 2.

Tytuł :: Catheter-Directed Therapy: Outcomes Versus Standard of Care and Evaluation of Current Practice.
Autorzy :: Zulty M; Department of Medicine, MedStar Union Memorial Hospital, Baltimore, MD.
Saleh N; Department of Medicine, MedStar Union Memorial Hospital, Baltimore, MD.
Hernandez J; Georgetown University School of Medicine, Washington, DC.
Kalaria A; Department of Radiology, MedStar Union Memorial Hospital, Baltimore, MD.
Camire L; Department of Medicine, MedStar Union Memorial Hospital, Baltimore, MD.
Weisman DS; Department of Medicine, MedStar Union Memorial Hospital, Baltimore, MD; Georgetown University School of Medicine, Washington, DC. Electronic address: .; Pokaż więcej
Źródło :: The American journal of medicine [Am J Med] 2021 Mar; Vol. 134 (3), pp. 400-404. Date of Electronic Publication: 2020 Nov 02.
Typ publikacji :: Comparative Study; Journal Article
MeSH Terms :: Catheterization*
Standard of Care*
Vena Cava Filters*
Pulmonary Embolism/*therapy
Thrombolytic Therapy/*methods
Tissue Plasminogen Activator/*administration & dosage
Aged ; Female ; Hospital Mortality ; Humans ; Male ; Middle Aged ; Pulmonary Embolism/mortality ; Retrospective Studies ; Treatment Outcome
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 3 3.

Tytuł :: Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof-of-concept clinical trial of new antivirals working against SARS-CoV-2-azithromycin trial.
Autorzy :: Gyselinck I; Katholieke Universiteit Leuven Universitaire Ziekenhuizen Leuven, Leuven, Belgium. .
Liesenborghs L; Katholieke Universiteit Leuven Universitaire Ziekenhuizen Leuven, Leuven, Belgium.
Landeloos E; Katholieke Universiteit Leuven Universitaire Ziekenhuizen Leuven, Leuven, Belgium.
Belmans A; Interuniversity Institute for Biostatistics and Statistical Bioinformatics, Leuven, Belgium.
Verbeke G; Interuniversity Institute for Biostatistics and Statistical Bioinformatics, Leuven, Belgium.
Verhamme P; Katholieke Universiteit Leuven Universitaire Ziekenhuizen Leuven, Leuven, Belgium.
Vos R; Katholieke Universiteit Leuven Universitaire Ziekenhuizen Leuven, Leuven, Belgium.
Janssens W; Katholieke Universiteit Leuven Universitaire Ziekenhuizen Leuven, Leuven, Belgium.; Pokaż więcej
Corporate Authors :: DAWn-Azithro consortium
Źródło :: Trials [Trials] 2021 Feb 09; Vol. 22 (1), pp. 126. Date of Electronic Publication: 2021 Feb 09.
Typ publikacji :: Clinical Trial Protocol; Journal Article
MeSH Terms :: Standard of Care*
Antiviral Agents/*adverse effects
Azithromycin/*adverse effects
COVID-19/*drug therapy
SARS-CoV-2/*genetics
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Antiviral Agents/administration & dosage ; Azithromycin/administration & dosage ; Belgium/epidemiology ; COVID-19/epidemiology ; COVID-19/virology ; Female ; Humans ; Hydroxychloroquine/therapeutic use ; Length of Stay ; Male ; Middle Aged ; Multicenter Studies as Topic ; Polymerase Chain Reaction ; Proof of Concept Study ; Randomized Controlled Trials as Topic ; Treatment Outcome ; Young Adult
SCR Protocol :: COVID-19 drug treatment
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 4 4.

Tytuł :: Crisis Standards of Care for the COVID-19 Pandemic: An Essential Resource for the PALTC Community.
Autorzy :: Wright J; AMDA Ethics Subcommittee, SNF/LTC Partners of Virginia, Richmond, VA, USA. Electronic address: .; Pokaż więcej
Źródło :: Journal of the American Medical Directors Association [J Am Med Dir Assoc] 2021 Feb; Vol. 22 (2), pp. 223-224. Date of Electronic Publication: 2020 Dec 07.
Typ publikacji :: Editorial; Introductory Journal Article
MeSH Terms :: Standard of Care*
COVID-19/*epidemiology
Disaster Planning/*standards
Nursing Homes/*standards
Humans ; Pandemics ; SARS-CoV-2 ; United States/epidemiology
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 5 5.

Tytuł :: Standard of care for adult Wilms tumor? From adult urologist to pediatric oncologist. A retrospective review.
Autorzy :: Sudour-Bonnange H; Oscar-Lambret center, department of pediatric oncology, AYA unit, Lille, France. Electronic address: .
Coulomb-Lherminé A; Trousseau hospital, department of pathology, Paris, France.
Fantoni JC; CHRU Lille, department of urologic surgery, Lille, France.
Escande A; Oscar-Lambret center, department of radiotherapy, Lille, France.
Brisse HJ; Institut Curie, department of imaging, Paris, France.
Thebaud E; CHRU Nantes, department of pediatric hemato-oncology, Nantes, France.
Verschuur A; AP-HM, La Timone Children's hospital, department of pediatric oncology and hematology, Marseille, France.; Pokaż więcej
Źródło :: Bulletin du cancer [Bull Cancer] 2021 Feb; Vol. 108 (2), pp. 177-186. Date of Electronic Publication: 2020 Oct 29.
Typ publikacji :: Journal Article; Review
MeSH Terms :: Standard of Care*
Kidney Neoplasms/*therapy
Rare Diseases/*therapy
Wilms Tumor/*therapy
Adult ; Age Factors ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Critical Pathways ; Female ; France ; Health Care Surveys/statistics & numerical data ; Humans ; Kidney Neoplasms/diagnosis ; Kidney Neoplasms/epidemiology ; Kidney Neoplasms/pathology ; Male ; Minimally Invasive Surgical Procedures ; Nephrectomy ; Oncologists ; Patient Care Team ; Pediatricians ; Pregnancy ; Pregnancy Complications, Neoplastic/diagnosis ; Pregnancy Complications, Neoplastic/therapy ; Radiotherapy ; Rare Diseases/diagnosis ; Rare Diseases/epidemiology ; Rare Diseases/pathology ; Retrospective Studies ; Urologists ; Wilms Tumor/diagnosis ; Wilms Tumor/epidemiology ; Wilms Tumor/pathology
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 6 6.

Tytuł :: US State Government Crisis Standards of Care Guidelines: Implications for Patients With Cancer.
Autorzy :: Hantel A; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts.; Division of Inpatient Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
Marron JM; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Oncology, Boston Children's Hospital, Boston, Massachusetts.; Center for Bioethics, Harvard Medical School, Boston, Massachusetts.
Casey M; Gastrointestinal Cancer Treatment Center, Dana-Farber Cancer Institute, Boston, Massachusetts.
Kurtz S; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts.
Magnavita E; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts.
Abel GA; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts.; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts.; Pokaż więcej
Źródło :: JAMA oncology [JAMA Oncol] 2021 Feb 01; Vol. 7 (2), pp. 199-205.
Typ publikacji :: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :: COVID-19*
Health Care Rationing*
Practice Guidelines as Topic*
Standard of Care*
State Government*
Neoplasms/*therapy
Cancer Care Facilities ; Cross-Sectional Studies ; Health Priorities ; Hospital Bed Capacity ; Humans ; National Cancer Institute (U.S.) ; Organ Dysfunction Scores ; Palliative Care ; Patient Rights ; SARS-CoV-2 ; United States
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 7 7.

Tytuł :: The Impact of SARS-CoV-2 Outbreak on the Polish Dental Community's Standards of Care-A Six-Month Retrospective Survey-Based Study.
Autorzy :: Dalewski B; Chair and Department of Dental Prosthetics, Pomeranian Medical University, 70-111 Szczecin, Poland.
Palka L; Private Dental Practice, 68-200 Żary, Poland.
Kiczmer P; Department and Chair of Pathomorphology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 40-752 Katowice, Poland.
Sobolewska E; Chair and Department of Dental Prosthetics, Pomeranian Medical University, 70-111 Szczecin, Poland.; Pokaż więcej
Źródło :: International journal of environmental research and public health [Int J Environ Res Public Health] 2021 Jan 31; Vol. 18 (3). Date of Electronic Publication: 2021 Jan 31.
Typ publikacji :: Journal Article
MeSH Terms :: COVID-19*
Dentists*
Standard of Care*
Dentistry/*trends
Dentistry/standards ; Female ; Headache/epidemiology ; Humans ; Male ; Poland/epidemiology ; Professional Role ; Retrospective Studies ; Surveys and Questionnaires ; Temporomandibular Joint Disorders/epidemiology
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 8 8.

Tytuł :: Salvage radiotherapy: a new standard of care.
Autorzy :: Sidaway P; . .; Pokaż więcej
Źródło :: Nature reviews. Clinical oncology [Nat Rev Clin Oncol] 2021 Jan; Vol. 18 (1), pp. 5.
Typ publikacji :: Journal Article; Comment
MeSH Terms :: Prostatectomy*
Standard of Care*
Humans ; Male ; Salvage Therapy
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 9 9.

Tytuł :: Pembrolizumab in MSI-H-dMMR Advanced Colorectal Cancer - A New Standard of Care.
Autorzy :: Grothey A; From GI Cancer Research, West Cancer Center and Research Institute, Germantown, TN.; Pokaż więcej
Źródło :: The New England journal of medicine [N Engl J Med] 2020 Dec 03; Vol. 383 (23), pp. 2283-2285.
Typ publikacji :: Editorial; Comment
MeSH Terms :: Colorectal Neoplasms*/genetics
Standard of Care*
Antibodies, Monoclonal, Humanized ; Humans ; Microsatellite Instability ; Microsatellite Repeats
: Opinia redakcyjna

Szczegóły

Skocz do pozycji: 10 10.

Tytuł :: [Robot-assisted cystectomy and urinary diversion, new standard of care ? What are the benefits ?]
Autorzy :: Adans-Dester G; Service d'urologie, HUG, 1211 Genève 14.
Grobet-Jeandin É; Service d'urologie, HUG, 1211 Genève 14.
Roosendaal A; Service d'urologie, HUG, 1211 Genève 14.
Iselin C; Service d'urologie, HUG, 1211 Genève 14.; Pokaż więcej
Transliterated Title :: Cystectomie et dérivation urinaire laparoscopique robot-assistée, nouveau standard ? Pour quels bénéfices ?
Źródło :: Revue medicale suisse [Rev Med Suisse] 2020 Dec 02; Vol. 16 (717), pp. 2339-2342.
Typ publikacji :: Journal Article
MeSH Terms :: Standard of Care*
Cystectomy/*methods
Robotic Surgical Procedures/*methods
Urinary Bladder Neoplasms/*surgery
Urinary Diversion/*methods
Humans ; Treatment Outcome
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 11 11.

Tytuł :: Activities related to inflammatory bowel disease management during and after the coronavirus disease 2019 lockdown in Italy: How to maintain standards of care.
Autorzy :: Saibeni S; Gastroenterology Unit, Rho Hospital, ASST Rhodense, Milan, Italy.
Scucchi L; Department of Systems Medicine, GI Unit, Policlinico Tor Vergata, University of Tor Vergata, Rome, Italy.
Dragoni G; Gastroenterology Unit, Careggi University Hospital Florence, Italy.
Bezzio C; Gastroenterology Unit, Rho Hospital, ASST Rhodense, Milan, Italy.
Miranda A; Gastroenterology and Endoscopy Unit, University of Campania 'L. Vanvitelli', Naples, Italy.
Ribaldone DG; Department of Medical Sciences, University of Turin, Turin, Italy.
Bertani A; Department of Gastroenterology, IBD Unit, Policlinico Hospital, Modena, Italy.
Bossa F; Division of Gastroenterology, IRCCS 'Casa Sollievo della Sofferenza' Foundation, San Giovanni Rotondo, Italy.
Allocca M; IBD Centre, Gastroenterology, Humanitas Clinical and Research Centre - IRCCS, Milan, Italy.; Department of Biomedical Sciences, Humanitas University, Milan, Italy.
Buda A; Department of Gastrointestinal Oncological Surgery, Gastroenterology and Endoscopy Unit, S. Maria del Prato Hospital, Feltre, Italy.
Mocci G; Gastroenterology Unit, Brotzu Hospital, Cagliari, Italy.
Soriano A; Gastroenterology Division, Azienda USL Arcispedale S. Maria Nuova - IRCCS di Reggio Emilia, Reggio Emilia, Italy.
Mazzuoli S; Gastroenterology and Artificial Nutrition Unit, Monsignor R. Dimiccoli Hospital, ASL BT, Barletta, Italy.
Bertani L; Gastroenterology and Digestive Endoscopy Department of Medical Specialties Apuane Hospital - Tuscany North-West ASL, Massa, Italy.
Baccini F; Digestive Disease Unit, Sant'Andrea University Hospital, Rome, Italy.
Loddo E; Gastroenterology Unit, University Hospital, AOU Cagliari, Cagliari, Italy.; Department of Medical Science and Public Health, University of Cagliari, Cagliari, Italy.
Privitera AC; IBD Unit, 'Cannizzaro' Hospital, Catania, Italy.
Sartini A; Gastroenterology and Digestive Endoscopy Unit, Forlì-Cesena, AUSL della Romagna, Rimini, Italy.
Viscido A; Gastroenterology Unit, Department of Life, Health and Environmental Sciences, University of L'Aquila, L'Aquila, Italy.
Grossi L; G. D'Annunzio University - Digestive Physiopathology, Ospedale Spirito Santo, Pescara, Italy.
Casini V; A.S.S.T. Bergamo EST, Gastroenterology Unit, Seriate Hospital, Bergamo, Italy.
Gerardi V; Department of Medicine, Gastroenterology and Endoscopy, Poliambulanza foundation, Brescia, Italy.
Ascolani M; Gastroenterology Unit, Santa Maria di Ca Foncello Hospital, Treviso, Italy.
Ruscio MD; IBD Unit, IRCCS Sacro Cuore Don Calabria, Negrar, Italy.
Casella G; ATS Brianza, Limbiate, Monza Brianza, Italy.
Savarino E; Gastroenterology Unit, Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy.
Stradella D; Gastroenterology Unit, A.O.U. Maggiore della Caritá, Novara, Italy.
Pumpo R; Endoscopy Unit P.O. S.G. Bosco, ASLNA1, Naples, Italy.
Cortelezzi CC; Gastroenterology and Endoscopy Unit, A.S.S.T. Sette Laghi, Varese, Italy.
Daperno M; Gastroenterology Unit, Mauriziano Hospital, Turin, Italy.
Ciardo V; Gastroenterology Unit, S. Antonio Hospital, San Daniele del Friuli, Italy.
Nardone OM; Gastroenterology, Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy.
Caprioli F; Gastroenterology and Endoscopy Unit, IRCCS Ca' Granda Ospedale Maggiore di Milano Policlinico Foundation, Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.
Vitale G; Gastroenterology and Endoscopy Unit, 'San Carlo' Hospital, Potenza, Italy.
Cappello M; IBD Clinic, Gastroenterology Section, Promise, University of Palermo, Palermo, Italy.
Comberlato M; IBD Unit, Department of Gastroenterology, Bolzano, Italy.
Alvisi P; Paediatric Gastroenterology Unit, Maggiore Hospital, Bologna, Italy.
Festa S; IBD Unit, S. Filippo Neri Hospital, Rome, Italy.
Campigotto M; Academic Surgical and Health Sciences Department, Trieste University, Trieste, Italy.
Bodini G; Gastroenterology chair, Internal Medicine Department, Genoa University, Italy.
Balestrieri P; Unit of Digestive Disease of Campus Bio Medico, University of Rome, Rome, Italy.
Viola A; IBD Unit, Department Clinical and experimental Medicine, Policlinico Messina, Messina, Italy.
Pugliese D; CEMAD - IBD Unit, Internal and Gastroenterology Unit, Academic Policlinic Foundation 'A. Gemelli' IRCCS, Rome, Italy.
Armuzzi A; CEMAD - IBD Unit, Internal and Gastroenterology Unit, Academic Policlinic Foundation 'A. Gemelli' IRCCS, Rome, Italy.
Fantini MC; Gastroenterology Unit, University Hospital, AOU Cagliari, Cagliari, Italy.; Department of Medical Science and Public Health, University of Cagliari, Cagliari, Italy.
Fiorino G; IBD Centre, Gastroenterology, Humanitas Clinical and Research Centre - IRCCS, Milan, Italy.; Department of Biomedical Sciences, Humanitas University, Milan, Italy.; Pokaż więcej
Corporate Authors :: IG-IBD (Italian Group for the study of Inflammatory Bowel Disease)
Źródło :: United European gastroenterology journal [United European Gastroenterol J] 2020 Dec; Vol. 8 (10), pp. 1228-1235. Date of Electronic Publication: 2020 Oct 18.
Typ publikacji :: Journal Article
MeSH Terms :: Standard of Care*/standards
COVID-19/*epidemiology
Inflammatory Bowel Diseases/*epidemiology
Critical Pathways ; Disease Management ; Humans ; Inflammatory Bowel Diseases/diagnosis ; Inflammatory Bowel Diseases/therapy ; Italy/epidemiology ; Pandemics ; Public Health Surveillance ; Quality of Life ; Surveys and Questionnaires
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 12 12.

Tytuł :: Phase I/II study protocol to assess safety and efficacy of adoptive cell therapy with anti-PD-1 plus low-dose pegylated-interferon-alpha in patients with metastatic melanoma refractory to standard of care treatments: the ACTME trial.
Autorzy :: van der Kooij MK; Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.
Verdegaal EME; Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.
Visser M; Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.
de Bruin L; Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.
van der Minne CE; Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.
Meij PM; Clinical Pharmacy & Toxicology, Leiden University Medical Center, Leiden, The Netherlands.
Roozen ICFM; Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.
Jonker MA; Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.
van den Bosch S; Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.
Liefers GJ; Surgery, Leids Universitair Medisch Centrum, Leiden, The Netherlands.
Speetjens FM; Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.
van der Burg SH; Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.
Kapiteijn E; Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands .; Pokaż więcej
Źródło :: BMJ open [BMJ Open] 2020 Nov 24; Vol. 10 (11), pp. e044036. Date of Electronic Publication: 2020 Nov 24.
Typ publikacji :: Clinical Trial Protocol; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Melanoma*/drug therapy
Standard of Care*
Cell- and Tissue-Based Therapy ; Clinical Trials, Phase I as Topic ; Clinical Trials, Phase III as Topic ; Humans ; Interferon-alpha ; Netherlands ; Polyethylene Glycols
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 13 13.

Tytuł :: Modified Antiretroviral Treatment Access Study (MARTAS): A Randomized Controlled Trial of the Efficacy of a Linkage-to-Care Intervention Among HIV-Positive Patients in Ukraine.
Autorzy :: Neduzhko O; Ukrainian Institute on Public Health Policy, 5 Mala Zhytomyrska str., Office 61A, Kiev, 01001, Ukraine. .
Postnov O; Ukrainian Institute on Public Health Policy, 5 Mala Zhytomyrska str., Office 61A, Kiev, 01001, Ukraine.
Sereda Y; Ukrainian Institute on Public Health Policy, 5 Mala Zhytomyrska str., Office 61A, Kiev, 01001, Ukraine.
Kulchynska R; Division of Global HIV and TB, U.S. Centers for Disease Control and Prevention, Kiev, Ukraine.
Bingham T; Division of Global HIV and TB, U.S. Centers for Disease Control and Prevention, Atlanta, USA.
Myers JJ; Prevention Research Center, University of California, San Francisco, USA.
Flanigan T; Alpert Medical School, Brown University, Providence, USA.
Kiriazova T; Ukrainian Institute on Public Health Policy, 5 Mala Zhytomyrska str., Office 61A, Kiev, 01001, Ukraine.; Pokaż więcej
Źródło :: AIDS and behavior [AIDS Behav] 2020 Nov; Vol. 24 (11), pp. 3142-3154.
Typ publikacji :: Journal Article; Randomized Controlled Trial
MeSH Terms :: Standard of Care*
Anti-Retroviral Agents/*therapeutic use
Case Management/*organization & administration
HIV Infections/*drug therapy
Patient-Centered Care/*methods
Adolescent ; Adult ; Aged ; Female ; HIV Infections/epidemiology ; HIV Infections/virology ; Humans ; Male ; Middle Aged ; Patient Acceptance of Health Care ; Pregnancy ; Retention in Care ; Treatment Outcome ; Ukraine/epidemiology
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 14 14.

Tytuł :: EULAR/eumusc.net standards of care for rheumatoid arthritis: cross-sectional analyses of importance, level of implementation and care gaps experienced by patients and rheumatologists across 35 European countries.
Autorzy :: Meisters R; Health Services Research, Maastricht University, Maastricht, The Netherlands .; Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands.
Putrik P; Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands.; Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center, Maastricht, The Netherlands.
Ramiro S; Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.; Rheumatology, Zuyderland Medical Center, Heerlen, The Netherlands.
Hifinger M; Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands.; Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center, Maastricht, The Netherlands.
Keszei AP; Center for Translational & Clinical Research Aachen (CTC-A), Uniklinik RWTH Aachen University, Aachen, Germany.
van Eijk-Hustings Y; Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center, Maastricht, The Netherlands.
Woolf AD; Bone and Joint Research Group, Royal Cornwall Hospital, Truro, UK.
Smolen JS; Division of Rheumatology, Department of Medicine, Medical University of Vienna, Vienna, Austria.
Stamm TA; Section for Outcomes Research, Center for Medical Statistics, Informatics, and Intelligent Systems, Medical University of Vienna, Vienna, Austria.
Stoffer-Marx M; Section for Outcomes Research, Center for Medical Statistics, Informatics, and Intelligent Systems, Medical University of Vienna, Vienna, Austria.; Internal Medicine III, Division of Rheumatology, Medical University of Vienna, Vienna, Austria.
Uhlig T; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway.
Moe RH; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway.
de Wit M; EULAR Patient Research Partner, Zaltbommel, The Netherlands.
Tafaj A; Rheumatology Clinic, Medical University of Tirana, Tirana, Albania.
Mukuchyan V; Department of Rheumatology, Erebouni Medical Center, Yerevan, Armenia.
Studenic P; Department of Internal Medicine 3, Division of Rheumatology, Medical University Vienna, Vienna, Austria.
Verschueren P; Rheumatology, University Hospitals Leuven, Leuven, Belgium.
Shumnalieva R; Clinic of Rheumatology, Department of Internal Medicine, Medical University-Sofia, Sofia, Bulgaria.
Charalambous P; Cyprus Society for Rheumatology, Nicosia, Cyprus.
Vencovský J; Institute of Rheumatology, Department of Rheumatology, Charles University, Prague, Czech Republic.
Varvouni M; Danish Hospital for Rheumatic Diseases, Sonderborg, Denmark.
Kull M; Department of Internal Medicine, Tartu University, Tartu, Estonia.
Puolakka K; Department of Medicine, Lappeenranta Central Hospital, Lappeenranta, Finland.
Gossec L; INSERM, Sorbonne Universite, Paris, Île-de-France, France.; Rheumatology, Hopital Universitaire Pitie Salpetriere, AP-HP, Paris, Île-de-France, France.
Gobejishvili N; Georgian Young Rheumatologists Union (SARG), Tbilisi, Georgia.
Detert J; Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Sidiropoulos P; Rheumatology, Allergy, Clinical Immunology, University of Crete, Thessaloniki, Greece.
Péntek M; Department of Health Economics, Corvinus University of Budapest, Budapest, Hungary.; Rheumatology, Flór Ferenc County Hospital, Kistarcsa, Hungary.
Kane D; Rheumatology, Trinity College Dublin, Dublin, Ireland.
Scirè CA; Epidemiology Unit, Italian Society for Rheumatology (SIR), Milan, Italy.
Arad U; Department of Rheumatology, Tel-Aviv Medical Center, Tel-Aviv, Israel.
Andersone D; Rheumatology, Pauls Stradina Clinical University Hospital, Riga, Latvia.
van de Laar M; Arthritis Center @ Medisch Spectrum Twente, Enschede, The Netherlands.; PHT, University of Twente, Enschede, The Netherlands.
van der Helm-van Mil A; Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.
Głuszko P; National Institute of Geriatrics, Rheumatology, and Rehabilitation, Warsaw, Poland.
Cunha-Miranda L; Rheumatology, Portuguese Institute of Rheumatology, Lisbon, Portugal.
Berghea F; Department of Internal Medicine and Rheumatology, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.
Damjanov NS; Rheumatology, University of Belgrade School of Medicine, Belgrade, Serbia.
Tomšič M; Department of Rheumatology, University Medical Centre Ljubljana, Ljubljana, Slovenia.
Carmona L; Instituto de Salud Musculoesquelética, Madrid, Spain.
Turesson C; Rheumatology, Department of Clinical Sciences, Lund University, Malmö, Sweden.
Ciurea A; Rheumatology, University Hospital Zurich, Zurich, Switzerland.
Shukurova S; Internal Medicine, Medical Science Academy, Dushanbe, Tajikistan.
Inanc N; Division of Rheumatology, School of Medicine, Marmara University, Istanbul, Turkey.
Verstappen SM; Centre for Epidemiology Versus Arthritis, Centre for Musculoskeletal Research, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.; NIHR Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom.
Boonen A; Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands.; Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center, Maastricht, The Netherlands.; Pokaż więcej
Corporate Authors :: Working group
Źródło :: Annals of the rheumatic diseases [Ann Rheum Dis] 2020 Nov; Vol. 79 (11), pp. 1423-1431. Date of Electronic Publication: 2020 Sep 01.
Typ publikacji :: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :: Arthritis, Rheumatoid*
Standard of Care*
Rheumatology/*standards
Adult ; Aged ; Cross-Sectional Studies ; Europe ; Female ; Humans ; Male ; Middle Aged ; Registries ; Rheumatologists ; Surveys and Questionnaires
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 15 15.

Tytuł :: Standards of care in mesothelioma treatment.
Autorzy :: Harden SV; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. .
Darlison L; University Hospitals of Leicester, Leicester, UK.
Beckett P; University Hospitals of Derby and Burton NHS Foundation Trust, Derby, UK.
Bibby AC; Academic Respiratory Unit, Bristol University, Bristol, UK.; Pokaż więcej
Źródło :: British journal of cancer [Br J Cancer] 2020 Nov; Vol. 123 (11), pp. 1588-1589. Date of Electronic Publication: 2020 Sep 22.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Standard of Care*
Medical Oncology/*standards
Mesothelioma/*therapy
Humans ; United Kingdom
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 16 16.

Tytuł :: Comparison and analyses of therapeutic effects between metabolic management center (MMC) and conventional management modes.
Autorzy :: Wang X; Beijing Key Laboratory of Diabetes Mellitus Prevention and Research, Department of Endocrinology, Beijing Luhe Hospital, Capital Medical University, 113 Xinhua South Road, Tongzhou District, Beijing City, 101100, China.
Zhao W; Beijing Key Laboratory of Diabetes Mellitus Prevention and Research, Department of Endocrinology, Beijing Luhe Hospital, Capital Medical University, 113 Xinhua South Road, Tongzhou District, Beijing City, 101100, China.
Ke J; Beijing Key Laboratory of Diabetes Mellitus Prevention and Research, Department of Endocrinology, Beijing Luhe Hospital, Capital Medical University, 113 Xinhua South Road, Tongzhou District, Beijing City, 101100, China.
Zhao D; Beijing Key Laboratory of Diabetes Mellitus Prevention and Research, Department of Endocrinology, Beijing Luhe Hospital, Capital Medical University, 113 Xinhua South Road, Tongzhou District, Beijing City, 101100, China. .; Pokaż więcej
Źródło :: Acta diabetologica [Acta Diabetol] 2020 Sep; Vol. 57 (9), pp. 1049-1056. Date of Electronic Publication: 2020 Apr 04.
Typ publikacji :: Comparative Study; Evaluation Study; Journal Article
MeSH Terms :: Comprehensive Health Care*/methods
Comprehensive Health Care*/organization & administration
Comprehensive Health Care*/standards
Self-Management*/economics
Self-Management*/methods
Self-Management*/psychology
Standard of Care*/economics
Standard of Care*/organization & administration
Standard of Care*/standards
Diabetes Mellitus, Type 2/*economics
Diabetes Mellitus, Type 2/*therapy
China/epidemiology ; Diabetes Mellitus, Type 2/epidemiology ; Diabetes Mellitus, Type 2/metabolism ; Female ; Health Care Costs ; Humans ; Male ; Middle Aged ; Patient Education as Topic/economics ; Patient Education as Topic/organization & administration ; Patient Education as Topic/standards ; Patient Satisfaction ; Program Evaluation ; Surveys and Questionnaires
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 17 17.

Tytuł :: Cancer survivorship needs in Brazil: Patient and family perspective.
Autorzy :: Santos ATCD; Population Research Division, Nucleus of Research and Qualitative Studies, National Cancer Institute, Rio de Janeiro, Brazil.
Silva RPD; Population Research Division, Nucleus of Research and Qualitative Studies, National Cancer Institute, Rio de Janeiro, Brazil.
Almeida LM; Division of Population Research, National Cancer Institute, Rio de Janeiro, Brazil.
Bosi MLM; Laboratory of Qualitative Research and Evaluation in Health, Federal University of Ceara, Fortaleza, Ceará, Brazil.
Menezes MFB; Population Research Division, Nucleus of Research and Qualitative Studies, National Cancer Institute, Rio de Janeiro, Brazil.
Skaba MMVF; Population Research Division, Nucleus of Research and Qualitative Studies, National Cancer Institute, Rio de Janeiro, Brazil.
Nigenda G; National School of Nursing and Obstetrics, National Autonomous University of México, México City, México.
Arruda CAM; Laboratory of Qualitative Research and Evaluation in Health, Federal University of Ceara, Fortaleza, Ceará, Brazil.
Pinheiro CPO; Laboratory of Qualitative Research and Evaluation in Health, Federal University of Ceara, Fortaleza, Ceará, Brazil.
González-Robledo MC; Centro de Investigación en Sistemas de Salud, Instituto Nacional de Salud Pública, Cuernavaca, Morelos, Mexico.
Knaul FM; Department of Public Health Sciences, University of Miami Miller School of Medicine, Coral Gables, Florida, United States of America.; Institute for Advanced Study of the Americas, University of Miami, Coral Gables, Florida, United States of America.; Programa Universalidad y Competitividad en Salud, Fundación Mexicana para la Salud, Mexico City, Mexico.; Tómatelo a Pecho, Mexico City, Mexico.; Pokaż więcej
Źródło :: PloS one [PLoS One] 2020 Oct 08; Vol. 15 (10), pp. e0239811. Date of Electronic Publication: 2020 Oct 08 (Print Publication: 2020).
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Cancer Survivors*
Health Services Needs and Demand*
Patient-Centered Care*
Psychosocial Support Systems*
Standard of Care*
Survivorship*
Adult ; Aged ; Brazil ; Family ; Female ; Health Services Accessibility ; Humans ; Male ; Middle Aged ; Qualitative Research ; Quality of Life/psychology ; Self-Help Groups ; Surveys and Questionnaires ; Young Adult
: Czasopismo naukowe

Szczegóły Pełny tekst

Skocz do pozycji: 18 18.

Tytuł :: Bimagrumab vs Optimized Standard of Care for Treatment of Sarcopenia in Community-Dwelling Older Adults: A Randomized Clinical Trial.
Autorzy :: Rooks D; Translational Medicine, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts.
Swan T; Translational Medicine, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts.
Goswami B; Novartis Healthcare, Hyderabad, India.; Now with MorphoSys, Planegg, Germany.
Filosa LA; Translational Medicine, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts.
Bunte O; Translational Medicine and Musculoskeletal Diseases Research, Novartis Institutes for BioMedical Research, Basel, Switzerland.
Panchaud N; Translational Medicine and Musculoskeletal Diseases Research, Novartis Institutes for BioMedical Research, Basel, Switzerland.
Coleman LA; Translational Medicine, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts.
Miller RR; Translational Medicine, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts.
Garcia Garayoa E; Translational Medicine and Musculoskeletal Diseases Research, Novartis Institutes for BioMedical Research, Basel, Switzerland.
Praestgaard J; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey.
Perry RG; Panax Clinical Research, Miami Lakes, Florida.
Recknor C; Center for Advanced Research and Education, Gainesville, Georgia.
Fogarty CM; Spartanburg Medical Research, Spartanburg, South Carolina.
Arai H; National Center for Geriatrics and Gerontology, Obu, Japan.
Chen LK; Center for Geriatrics and Gerontology, Taipei Veterans General Hospital, Taipei, Taiwan.
Hashimoto J; National Hospital Organization, Osaka Minami Medical Center, Osaka, Japan.
Chung YS; Ajou University School of Medicine, Suwon, South Korea.
Vissing J; Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Laurent D; Translational Medicine and Musculoskeletal Diseases Research, Novartis Institutes for BioMedical Research, Basel, Switzerland.
Petricoul O; Translational Medicine and Musculoskeletal Diseases Research, Novartis Institutes for BioMedical Research, Basel, Switzerland.
Hemsley S; Translational Medicine and Musculoskeletal Diseases Research, Novartis Institutes for BioMedical Research, Basel, Switzerland.
Lach-Trifilieff E; Translational Medicine and Musculoskeletal Diseases Research, Novartis Institutes for BioMedical Research, Basel, Switzerland.
Papanicolaou DA; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey.
Roubenoff R; Translational Medicine and Musculoskeletal Diseases Research, Novartis Institutes for BioMedical Research, Basel, Switzerland.; Pokaż więcej
Źródło :: JAMA network open [JAMA Netw Open] 2020 Oct 01; Vol. 3 (10), pp. e2020836. Date of Electronic Publication: 2020 Oct 01.
Typ publikacji :: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :: Standard of Care*
Antibodies, Monoclonal, Humanized/*therapeutic use
Exercise Therapy/*methods
Sarcopenia/*therapy
Accidental Falls/prevention & control ; Aged ; Aged, 80 and over ; Combined Modality Therapy ; Dietary Supplements ; Double-Blind Method ; Female ; Humans ; Independent Living ; Motor Skills Disorders/prevention & control ; Quality of Life ; Sarcopenia/drug therapy ; Treatment Outcome
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 19 19.

Tytuł :: Is Telehealth Here To Stay.
Źródło :: Oncology (Williston Park, N.Y.) [Oncology (Williston Park)] 2020 Sep 15; Vol. 34 (9), pp. 377-378.
Typ publikacji :: Interview
MeSH Terms :: Delivery of Health Care*
Reimbursement Mechanisms*
Standard of Care*
Telemedicine/*trends
Betacoronavirus ; COVID-19 ; Coronavirus Infections/epidemiology ; Humans ; Pandemics ; Pneumonia, Viral/epidemiology ; SARS-CoV-2 ; Telemedicine/economics ; Telemedicine/methods ; Telemedicine/standards

Szczegóły

Skocz do pozycji: 20 20.

Tytuł :: A Systematic Review on Guidelines and Recommendations for Urology Standard of Care During the COVID-19 Pandemic.
Autorzy :: Heldwein FL; Federal University of Santa Catarina and Baiasul Medical Hospital, Florianopolis, Brazil; Hospital Israelita Albert Einstein, Sao Paulo, Brazil. Electronic address: .
Loeb S; New York University and Manhattan Veterans Affairs Medical Center, New York, NY, USA.
Wroclawski ML; Hospital Israelita Albert Einstein, Sao Paulo, Brazil; Hospital Beneficiencia Portuguesa, Sao Paulo, Brazil.
Sridhar AN; University College London Hospitals, London, UK.
Carneiro A; Hospital Israelita Albert Einstein, Sao Paulo, Brazil.
Lima FS; Universidade Estadual do Sudoeste da Bahia, Salvador, Brazil.
Teoh JY; S.H. Ho Urology Centre, Department of Surgery, The Chinese University of Hong Kong, Hong Kong, China.; Pokaż więcej
Źródło :: European urology focus [Eur Urol Focus] 2020 Sep 15; Vol. 6 (5), pp. 1070-1085. Date of Electronic Publication: 2020 Jun 05.
Typ publikacji :: Journal Article; Systematic Review
MeSH Terms :: Practice Guidelines as Topic*
Standard of Care*
Coronavirus Infections/*epidemiology
Pneumonia, Viral/*epidemiology
Urologic Neoplasms/*surgery
Urology/*standards
Betacoronavirus ; COVID-19 ; Clinical Decision-Making ; Endoscopy/methods ; Humans ; Laparoscopy/methods ; Neoplasm Grading ; Neoplasm Staging ; Pandemics ; Robotic Surgical Procedures/methods ; SARS-CoV-2 ; Urologic Diseases/surgery ; Urologic Neoplasms/pathology ; Urologic Surgical Procedures/methods
: Czasopismo naukowe

Szczegóły

Informacja

Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Standard of Care"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język